InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,967.23
(
-0.88%
)
US TECH 100
16,556.80
(
-2.24%
)
Dow Jones
37,986.40
(
0.56%
)
Brent Oil
86.63
(
0.00%
)
Bitcoin
64,005.40
(
0.28%
)
Post# of 8163
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Hooka

Send PM Follow Ignore
Followers 736
Posts 69046
Boards Moderated 2
Alias Born 06/03/2009

Hooka

Re: None

Monday, 10/06/2014 8:59:46 AM

Monday, October 06, 2014 8:59:46 AM

Post# of 8163
Compensated Awareness Post View Disclaimer
$IMMB - The toxicity testing of ITV-1 on animals has also been successfully completed as well as a complete pharmacokinetics (PK) analysis of how the treatment is distributed through the blood system. The Company is making its application for the permit to move to Phase III full scale clinical testing on patients. The initial testing will begin upon receipt of the Phase III permit which the Company expects to receive within 60 days of acceptance of the application.

http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-successful-130000876.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up